Fil LTD Biomarin Pharmaceutical Inc Transaction History

Fil LTD

$103 Billion
Q3 2024

A detailed history of Fil LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Fil LTD holds 4,476 shares of BMRN stock, worth $283,867. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,476

Previous 6,842 34.58%

Holding current value

$283,867

Previous $563,000 44.23%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$69.02 - $93.84 $163,301 - $222,025	-2,366 Reduced 34.58%	4,476 $314,000
Q2 2024 Aug 13, 2024	BUY	$74.43 - $92.22 $509,250 - $630,969	6,842 New	6,842 $563,000
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $11,732 - $14,238	-157 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$72.61 - $90.2 $26,212 - $32,562	-361 Reduced 69.69%	157 $14,000
Q3 2020 Nov 13, 2020	BUY	$71.87 - $131.03 $2,515 - $4,586	35 Added 7.25%	518 $39,000
Q2 2020 Aug 13, 2020	BUY	$79.55 - $124.22 $38,422 - $59,998	483 New	483 $60,000
Q1 2020 May 14, 2020	SELL	$71.37 - $96.85 $4,210 - $5,714	-59 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$64.27 - $86.37 $3,791 - $5,095	59 New	59 $5,000
Q3 2019 Nov 13, 2019	SELL	$67.4 - $85.11 $4.16 Million - $5.26 Million	-61,753 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$80.35 - $93.9 $1.8 Million - $2.1 Million	-22,359 Reduced 26.58%	61,753 $5.29 Million
Q1 2019 May 13, 2019	SELL	$84.2 - $98.62 $21,723 - $25,443	-258 Reduced 0.31%	84,112 $7.47 Million
Q4 2018 Feb 13, 2019	SELL	$80.14 - $106.07 $343,239 - $454,297	-4,283 Reduced 4.83%	84,370 $7.18 Million
Q3 2018 Nov 09, 2018	SELL	$93.92 - $105.72 $24.7 Million - $27.8 Million	-262,912 Reduced 74.78%	88,653 $8.6 Million
Q2 2018 Aug 10, 2018	SELL	$76.01 - $99.03 $2.68 Million - $3.5 Million	-35,304 Reduced 9.13%	351,565 $33.1 Million
Q1 2018 May 14, 2018	SELL	$77.67 - $92.63 $4.82 Million - $5.75 Million	-62,110 Reduced 13.83%	386,869 $31.4 Million
Q4 2017 Feb 12, 2018	SELL	$80.76 - $95.13 $4.69 Million - $5.53 Million	-58,126 Reduced 11.46%	448,979 $40 Million
Q3 2017 Nov 13, 2017	SELL	$80.6 - $94.95 $899,415 - $1.06 Million	-11,159 Reduced 2.15%	507,105 $47.2 Million
Q2 2017 Aug 29, 2017	BUY	N/A	518,264	518,264 $47.1 Million

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Account